ARCHIVES

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

This article is from The Cancer Letter archive.

Vol. 25 No. 1 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

Weekly Paclitaxel, Carboplatin Safer For Advanced Lung Cancer, Study Finds

August 31, 2001

In Brief: Hellman Succeeds Perez As ASTR President Hanks Named President Elect; Kligerman Gold Medalist

November 5, 1982

NIH Considering Longer grant Award Periods; CCIRC’s New Bosses Crack Dow On Conferences

November 10, 1978

ACS California Division Offers Fellowships For Clinical Research

June 14, 1996

Amgen Says ESA Use Dropped By Half In Fourth Quarter.

January 25, 2008

RFA For Patterns Of Care Studies Announced By DCCR

November 10, 1978